Prentice Wealth Management’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
Other funds holding HSTO
AC
VF
UCFA
Prentice Wealth Management's HSTO Position: Q4 2021 in Review
Prentice Wealth Management sold out of Histogen Inc. Common Stock (HSTO) in Q4 2021, closing a stake of 50 shares — an estimated $1K sold.
Prentice Wealth Management first reported a position in HSTO in Q1 2021 and held it in 3 quarters. The position peaked at $3K in Q1 2021. 24 funds tracked by Wall St. Rank hold HSTO as of Q4 2021.
- Prentice Wealth Management reported no remaining Histogen Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
- Prentice Wealth Management sold 50 Histogen Inc. Common Stock shares in Q4 2021, an estimated $1K.
- Prentice Wealth Management first reported a position in Histogen Inc. Common Stock in Q1 2021 and held it in 3 quarters.
- Prentice Wealth Management's Histogen Inc. Common Stock position peaked at $3K in Q1 2021.
- 24 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2021.
Based on Prentice Wealth Management's 13F filing for Q4 2021, filed 31 Oct 2022.